Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies

Orbai, A-M, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (4 more authors) (2022) Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies. BMC Rheumatology, 6 (1). 68. ISSN 2520-1026

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2022. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0)

Keywords: Spondyloarthritis; Psoriatic arthritis; Patient-reported outcomes; Dactylitis; Tofacitinib
Dates:
  • Published: 1 September 2022
  • Published (online): 1 September 2022
  • Accepted: 30 July 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Sep 2022 13:51
Last Modified: 22 Sep 2022 13:51
Status: Published
Publisher: BMC
Identification Number: 10.1186/s41927-022-00298-4
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics